receptors, which cause the liver to break down fatty acids. The actions seemingly mimic those of drugs like Fenofibrate, used to reduce lipids, and Rosiglitazone, an anti-diabetic drug. An expert in nanobiology, as well as physics, engineering and biology, said the Rappaport Institute, Nahmias then developed